Katholieke Universiteit Leuven Opening the door for immunotherapy in acute myeloid leukemia: targeting mutant NPM1 with T-cell receptor-like chimeric antigen receptors. 2024 Leuven Health Support € 190,000 As part of Research into the pathobiology of hematological cancers Research into the pathobiology of hematological cancers with an aim to advanced treatment Read more Have also benefited from support De Duve Institute Unraveling Metabolic Crosstalk in Leukemic Bone Marrow: Characterizing the Importance and Microenvironmental Reprogramming of PFKFB-Driven Metabolism in Acute Myeloid Leukemia Read more Stay informed about new grantees Subscribe for e-news
Research into the pathobiology of hematological cancers Research into the pathobiology of hematological cancers with an aim to advanced treatment Read more
De Duve Institute Unraveling Metabolic Crosstalk in Leukemic Bone Marrow: Characterizing the Importance and Microenvironmental Reprogramming of PFKFB-Driven Metabolism in Acute Myeloid Leukemia Read more